120 related articles for article (PubMed ID: 12765073)
1. [Prostatic cancer in the young adult].
Sfaxi M; Miladi M; Bacha K; Zermani R; Chebil M; Ayed M
Prog Urol; 2003 Apr; 13(2):313-5. PubMed ID: 12765073
[TBL] [Abstract][Full Text] [Related]
2. Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.
Ryan CJ; Zelefsky MJ; Heller G; Regan K; Leibel SA; Scher HI; Kelly WK
Urology; 2004 Jul; 64(1):90-4. PubMed ID: 15245942
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
4. [A case of advanced prostatic cancer in a 44-year-old treated effectively with combination chemo-endocrine therapy].
Araki S; Kusuyama H; Kato M; Okada K
Hinyokika Kiyo; 1990 Apr; 36(4):465-9. PubMed ID: 1696064
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of adjuvant intermittent endocrine therapy following neoadjuvant endocrine therapy and external beam radiation therapy in men with locally advanced prostate cancer.
Yamanaka H; Ito K; Naito S; Tsukamoto T; Usami M; Fujimoto H; Matsuoka N; Fukui I; Harada M; Ohashi Y; Kotake T; Kakizoe T
Prostate; 2005 Apr; 63(1):56-64. PubMed ID: 15468166
[TBL] [Abstract][Full Text] [Related]
6. Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer.
Copp H; Bissonette EA; Theodorescu D
Urology; 2005 Jun; 65(6):1146-51. PubMed ID: 15922433
[TBL] [Abstract][Full Text] [Related]
7. [Indications of the association of radiotherapy and hormonal treatment in prostate cancer].
Bolla M; Maingon P; Fourneret P; Artignan X; Descotes JL
Cancer Radiother; 2005 Nov; 9(6-7):394-8. PubMed ID: 16226044
[TBL] [Abstract][Full Text] [Related]
8. [Effect of tegafur administration combined with hormonal therapy in patients with newly diagnosed stage D prostatic cancer].
Kobayashi N; Yoshida K; Takahashi T; Saitoh H; Tari K; Satake I; Kojima S; Tsujii T; Negishi T; Horiuchi S
Hinyokika Kiyo; 1990 Jul; 36(7):793-800. PubMed ID: 2239576
[TBL] [Abstract][Full Text] [Related]
9. [Curative radiotherapy in stage C prostatic carcinoma. Experiences with radiotherapy-endocrine treatment].
Klosterhalfen H; Becker H; Köllermann MW; Altenähr E
Urologe A; 1983 Sep; 22 Suppl():360-6. PubMed ID: 6314624
[TBL] [Abstract][Full Text] [Related]
10. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
11. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Miller N; Smolkin ME; Bissonette E; Theodorescu D
Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
[TBL] [Abstract][Full Text] [Related]
12. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study of prostatic carcinoma].
Hashimoto H; Sasaki M; Osanai H; Inagaki N; Yamauchi K; Nishihara M; Tokunaka S; Yachiku S
Hinyokika Kiyo; 1989 Feb; 35(2):271-5. PubMed ID: 2735238
[TBL] [Abstract][Full Text] [Related]
14. [Sequential histological studies of prostatic adenocarcinoma after treatment].
Sakamoto A; Kawai T; Kitagawa T; Sugano H
Gan No Rinsho; 1983 Oct; 29(12):1433-40. PubMed ID: 6645062
[TBL] [Abstract][Full Text] [Related]
15. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
Rosenthal SA; Bae K; Pienta KJ; Sobczak ML; Asbell SO; Rajan R; Kerlin KJ; Michalski JM; Sandler HM;
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):672-8. PubMed ID: 18990504
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer.
Hashine K; Numata K; Azuma K; Sumiyoshi Y; Kataoka M
Jpn J Clin Oncol; 2005 Nov; 35(11):655-9. PubMed ID: 16275680
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up after triple treatment of prostate cancer stage pT3.
Schelin S; Madsen M; Palmqvist E; Mäkelä E; Klintenberg C; Aus G
Scand J Urol Nephrol; 2009; 43(3):186-91. PubMed ID: 19353383
[TBL] [Abstract][Full Text] [Related]
18. High dose rate and external beam radiotherapy in locally advanced prostate cancer.
Viani GA; Pellizzon AC; Guimarães FS; Jacinto AA; dos Santos Novaes PE; Salvajoli JV
Am J Clin Oncol; 2009 Apr; 32(2):187-90. PubMed ID: 19307949
[TBL] [Abstract][Full Text] [Related]
19. [High risk prostate cancer results of one year RT-HT].
Delaporte V; Muracciole X; Lechevalier E; Bastide C; Cowen D; Rossi D; Coulange C
Prog Urol; 2005 Dec; 15(6 Suppl 1):1256-61. PubMed ID: 16734214
[No Abstract] [Full Text] [Related]
20. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
King CR; Presti JC; Gill H; Brooks J; Hancock SL
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):341-7. PubMed ID: 15145146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
